Plain Language Summary: People with hemophilia A often need specialized blood tests to monitor how well their treatment is working, but these tests are not always easy to access. Researchers developed the EnzySystem, a new near-patient testing device that can measure factor VIII activity and blood clotting from a small blood sample in about an hour.
Surveys of healthcare providers, patients, and caregivers showed strong interest in the device. Patients were especially interested in using it at home, while healthcare providers saw value in using it in clinics to provide faster results. Participants agreed that test accuracy, quick turnaround times, and improved access are essential for successful adoption.
